Cargando…

The Dashboard Vitals of Parkinson’s: Not to Be Missed Yet an Unmet Need

Detalles Bibliográficos
Autores principales:	Chaudhuri, Kallol Ray, Titova, Nataliya, Qamar, Mubasher A., Murășan, Iulia, Falup-Pecurariu, Cristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780936/ https://www.ncbi.nlm.nih.gov/pubmed/36556215 http://dx.doi.org/10.3390/jpm12121994

Ejemplares similares

Chaudhuri’s Dashboard of Vitals in Parkinson’s syndrome: an unmet need underpinned by real life clinical tests
por: Qamar, Mubasher A., et al.
Publicado: (2023)

Editorial: Movement Disorders and Sleep – Underlying Mechanisms, Clinical Aspects and Treatment
por: Falup-Pecurariu, Cristian, et al.
Publicado: (2019)

SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
por: Boura, Iro, et al.
Publicado: (2023)

Dry eye in Parkinson's disease: a narrative review
por: Ungureanu, Larisa, et al.
Publicado: (2023)

Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
por: Tall, P., et al.
Publicado: (2023)

Personalized Assessment of Insomnia and Sleep Quality in Patients with Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2022)

Parkinson's Disease and Post–COVID‐19 Syndrome: The Parkinson's Long‐COVID Spectrum
por: Leta, Valentina, et al.
Publicado: (2021)

Hiccups, Hypersalivation, Hallucinations in Parkinson’s Disease: New Insights, Mechanisms, Pathophysiology, and Management
por: Metta, Vinod, et al.
Publicado: (2023)

Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
por: Titova, Nataliya, et al.
Publicado: (2017)

Personalized medicine in Parkinson's disease: Time to be precise
por: Titova, Nataliya, et al.
Publicado: (2017)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

Nocturia and Sleep in Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Management of Orthostatic Hypotension in Parkinson’s Disease
por: Fanciulli, Alessandra, et al.
Publicado: (2020)

Restless Legs Syndrome in Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience
por: Metta, Vinod, et al.
Publicado: (2023)

Evidence for short duration of antibiotic treatment for non-severe community acquired pneumonia (CAP) in children — are we there yet? A systematic review of randomised controlled trials
por: Ben-Shimol, Shalom, et al.
Publicado: (2014)

Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
por: Todorova, Antoniya, et al.
Publicado: (2014)

Parkinson’s: a syndrome rather than a disease?
por: Titova, Nataliya, et al.
Publicado: (2016)

A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need
por: Ray Chaudhuri, Kallol, et al.
Publicado: (2013)

Correction: A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need
por: Ray Chaudhuri, Kallol, et al.
Publicado: (2016)

Shiga toxin producing Escherichia coli-associated diarrhea and hemolytic uremic syndrome in young children in Romania
por: Falup-Pecurariu, Oana, et al.
Publicado: (2019)

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey
por: Rizos, A., et al.
Publicado: (2020)

Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care
por: Rukavina, Katarina, et al.
Publicado: (2022)

Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far
por: Boura, Iro, et al.
Publicado: (2022)

Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future
por: Ray Chaudhuri, K, et al.
Publicado: (2016)

Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
por: Rosa-Grilo, Miguel, et al.
Publicado: (2017)

Treatment paradigms in Parkinson's Disease and Covid-19
por: Boura, Iro, et al.
Publicado: (2022)

‘Levodopa Phobia’: a review of a not uncommon and consequential phenomenon
por: Titova, Nataliya, et al.
Publicado: (2018)

Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
por: Buhidma, Yazead, et al.
Publicado: (2020)

Von Dashboards zu Dashboarding
por: Feldmann, Marc, et al.
Publicado: (2021)

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease
por: Jenner, P., et al.
Publicado: (2023)

The missing vital sign
por: Mangurian, Christina, et al.
Publicado: (2013)

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease
por: Wilson, Heather, et al.
Publicado: (2018)

Is It Over Yet? Did I Miss Anything?
por: Berkowitz, Carol D.
Publicado: (2023)

Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
por: Leta, Valentina, et al.
Publicado: (2022)

Family planning needs to limit childbearing are unmet, yet our parity is high: characterizing and unveiling the predictive factors
por: Adebowale, A. S., et al.
Publicado: (2023)

Melioidosis—Commonly Missed, Yet Not Uncommon and Eminently Treatable
por: Gopalakrishnan, Ram
Publicado: (2021)

Strongyloides stercoralis: Uncommon yet not to be missed cause of eosinophilia
por: Boccucci, Jacob M., et al.
Publicado: (2022)

Dashboards for Excel
por: Goldmeier, Jordan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lumf481l9pvn9c6bs7hnef577l